Stand-alone CI takes a nose-dive

Sales of stand-alone critical illness (CI) products have plummeted in the first two quarters of 2008, according to figures released by the Association of British Insurers (ABI). In a table distributed by the body which detailed sales of protection products, the value of total new premiums for the product fell from £11m in Q1 and Q2 of 2007 to £4m in the same periods for 2008. In contrast, sales of Income Protection (IP) remained steady with a 2007 range of £12-14m being carried over into 2008 with the first two quarters showing the total new premiums to be £14m. Jon French, assistant ...